We are live on ! Find out more
JF

Jump Financial Portfolio holdings

AUM $7.5B
1-Year Est. Return 33.9%
This Fund
S&P 500
This Quarter Est. Return
-3.61%
1 Year Est. Return
+33.9%
3 Year Est. Return
+69.87%
5 Year Est. Return
+55.07%
10 Year Est. Return
AUM
$2.57B
AUM Growth
+$237M
Cap. Flow
+$461M
Cap. Flow %
17.93%
Top 10 Hldgs %
8.13%
Holding
2,154
New
603
Increased
475
Reduced
443
Closed
629

Sector Composition

Rank Sector Weight
1 Technology 19.51%
2 Financials 12.11%
3 Healthcare 12%
4 Industrials 10.02%
5 Consumer Discretionary 7.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VNDA icon
901
Vanda Pharmaceuticals
VNDA
$307M
$504K 0.02%
51,000
-3,100
-6% -$32.7K
EBIX
902
DELISTED
Ebix Inc
EBIX
$503K 0.02%
+26,500
New +$583K
ITUB icon
903
Itaú Unibanco
ITUB
$93.2B
$501K 0.02%
109,781
-612,374
-85% -$2.61M
CXM icon
904
Sprinklr
CXM
$1.49B
$500K 0.02%
+54,237
New +$611K
HCAT icon
905
Health Catalyst
HCAT
$154M
$497K 0.02%
+51,250
New +$679K
OSPN icon
906
OneSpan
OSPN
$574M
$497K 0.02%
57,692
+29,092
+102% +$314K
BKNG icon
907
Booking.com
BKNG
$149B
$494K 0.02%
+7,525
New +$565K
DSGR icon
908
Distribution Solutions Group
DSGR
$1.6B
$493K 0.02%
+35,056
New +$760K
GTHX
909
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$493K 0.02%
39,500
-1,554
-4% -$17.8K
ADSK icon
910
Autodesk
ADSK
$49.5B
$491K 0.02%
+2,629
New +$531K
ON icon
911
ON Semiconductor
ON
$31.8B
$490K 0.02%
+7,858
New +$506K
RARE icon
912
Ultragenyx Pharmaceutical
RARE
$2.45B
$489K 0.02%
+11,798
New +$606K
LH icon
913
Labcorp
LH
$25B
$488K 0.02%
2,771
-20,194
-88% -$4.13M
ESS icon
914
Essex Property Trust
ESS
$18.3B
$484K 0.02%
2,000
-19,348
-91% -$5.23M
OLED icon
915
Universal Display
OLED
$3.68B
$482K 0.02%
+5,104
New +$565K
CHRW icon
916
C.H. Robinson
CHRW
$17.4B
$481K 0.02%
+4,999
New +$537K
BNL icon
917
Broadstone Net Lease
BNL
$4.11B
$480K 0.02%
+30,900
New +$627K
LECO icon
918
Lincoln Electric
LECO
$14.2B
$478K 0.02%
3,802
-3,398
-47% -$459K
BEN icon
919
Franklin Resources
BEN
$17.6B
$476K 0.02%
+22,130
New +$569K
CDRE icon
920
Cadre Holdings
CDRE
$1.32B
$469K 0.02%
19,500
-11,367
-37% -$278K
NTLA icon
921
Intellia Therapeutics
NTLA
$1.49B
$467K 0.02%
8,352
-64,048
-88% -$3.97M
ITCI
922
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$465K 0.02%
+10,000
New +$522K
ORGO icon
923
Organogenesis Holdings
ORGO
$305M
$464K 0.02%
143,414
+107,410
+298% +$485K
PRA
924
DELISTED
ProAssurance
PRA
$464K 0.02%
+23,762
New +$522K
ARGX icon
925
argenx
ARGX
$53.4B
$462K 0.02%
1,309
-12,191
-90% -$4.52M

Similar funds

Jump Financial's Q3 2022 Portfolio in Review

As of Q3 2022, Jump Financial held 2,154 positions worth $2.57B, up 10% from $2.33B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.

Jump Financial deployed $461M of net new capital in Q3 2022, opening 603 new positions and adding to 475 existing holdings. Its largest new stake was State Street SPDR Dow Jones Industrial Average ETF Trust: 64,217 shares worth $18.4M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $44.4M trimmed.

  • Jump Financial's largest Q3 2022 buy was State Street SPDR Dow Jones Industrial Average ETF Trust: 64,217 shares worth $18.4M.
  • Jump Financial added most to ProShares UltraPro QQQ in Q3 2022, an estimated $23.5M increase.
  • Jump Financial's biggest Q3 2022 reduction was Vanguard S&P 500 ETF, cutting an estimated $44.4M.
  • Jump Financial fully exited Invesco QQQ Trust in Q3 2022, selling an estimated $94.5M.
  • Jump Financial's ten largest holdings make up 8.1% of its $2.57B portfolio in Q3 2022.
  • Jump Financial opened 603 new positions and closed 629 in Q3 2022.
  • Jump Financial's portfolio value rose 10% quarter-over-quarter to $2.57B.

Based on Jump Financial's 13F filing for Q3 2022, filed 7 Nov 2022.